These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 30781383)
1. Design and Evaluation of An Extended-Release Olmesartan Tablet Using Chitosan/Cyclodextrin Composites. Anraku M; Tabuchi R; Goto M; Iohara D; Mizukai Y; Maezaki Y; Michihara A; Kadowaki D; Otagiri M; Hirayama F Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781383 [TBL] [Abstract][Full Text] [Related]
2. Slow-release of famotidine from tablets consisting of chitosan/sulfobutyl ether β-cyclodextrin composites. Anraku M; Hiraga A; Iohara D; Pipkin JD; Uekama K; Hirayama F Int J Pharm; 2015 Jun; 487(1-2):142-7. PubMed ID: 25882010 [TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD. Okimoto K; Ohike A; Ibuki R; Aoki O; Ohnishi N; Irie T; Uekama K; Rajewski RA; Stella VJ Pharm Res; 1999 Apr; 16(4):549-54. PubMed ID: 10227711 [TBL] [Abstract][Full Text] [Related]
4. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation. Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157 [TBL] [Abstract][Full Text] [Related]
5. Controlled and complete release of a model poorly water-soluble drug, prednisolone, from hydroxypropyl methylcellulose matrix tablets using (SBE)(7m)-beta-cyclodextrin as a solubilizing agent. Rao VM; Haslam JL; Stella VJ J Pharm Sci; 2001 Jul; 90(7):807-16. PubMed ID: 11458330 [TBL] [Abstract][Full Text] [Related]
6. Inclusion Complex of Docetaxel with Sulfobutyl Ether β-Cyclodextrin: Preparation, In Vitro Cytotoxicity and In Vivo Safety. Ren L; Yang X; Guo W; Wang J; Chen G Polymers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066097 [TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD. Okimoto K; Miyake M; Ohnishi N; Rajewski RA; Stella VJ; Irie T; Uekama K Pharm Res; 1998 Oct; 15(10):1562-8. PubMed ID: 9794499 [TBL] [Abstract][Full Text] [Related]
8. Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent. Okimoto K; Rajewski RA; Stella VJ J Control Release; 1999 Mar; 58(1):29-38. PubMed ID: 10021487 [TBL] [Abstract][Full Text] [Related]
9. Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac. Xu Y; Zhang C; Zhu X; Wang X; Wang H; Hu G; Fu Q; He Z Expert Opin Drug Deliv; 2019 Jun; 16(6):657-666. PubMed ID: 31033370 [No Abstract] [Full Text] [Related]
10. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides. Trapani A; Lopedota A; Franco M; Cioffi N; Ieva E; Garcia-Fuentes M; Alonso MJ Eur J Pharm Biopharm; 2010 May; 75(1):26-32. PubMed ID: 20102738 [TBL] [Abstract][Full Text] [Related]
12. Biomaterials based on freeze dried surface-deacetylated chitin nanofibers reinforced with sulfobutyl ether β-cyclodextrin gel in wound dressing applications. Tabuchi R; Azuma K; Izumi R; Tanou T; Okamoto Y; Nagae T; Iohara D; Uekama K; Otagiri M; Hirayama F; Ifuku S; Anraku M Int J Pharm; 2016 Sep; 511(2):1080-7. PubMed ID: 27521704 [TBL] [Abstract][Full Text] [Related]
13. Inclusion Complex of Isoliquiritigenin With Sulfobutyl Ether-β-Cyclodextrin: Preparation, Characterization, Inclusion Mode, Solubilization, and Stability. Wu X; Li J; Hu C; Zheng Y; Zhang Y; Li J; Li M; Xiao D; Lu L; Huang Y; Zhang X; Li C Front Chem; 2022; 10():930297. PubMed ID: 35800032 [TBL] [Abstract][Full Text] [Related]
14. Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion. Fukuda M; Miller DA; Peppas NA; McGinity JW Int J Pharm; 2008 Feb; 350(1-2):188-96. PubMed ID: 17920217 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of stereoselective dissolution of racemic salbutamol matrices prepared with commonly used excipients and 1H-NMR study. Srichana T; Suedee R Drug Dev Ind Pharm; 2001 May; 27(5):457-64. PubMed ID: 11448053 [TBL] [Abstract][Full Text] [Related]
16. Optimization of sulfobutyl-ether-β-cyclodextrin levels in oral formulations to enhance progesterone bioavailability. Shankar VK; Police A; Pandey P; Cuny ZG; Repka MA; Doerksen RJ; Murthy SN Int J Pharm; 2021 Mar; 596():120212. PubMed ID: 33493605 [TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery. Zhang P; Liu X; Hu W; Bai Y; Zhang L Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746 [TBL] [Abstract][Full Text] [Related]
19. Development and physicochemical characterization of chitosan hydrochloride/sulfobutyl ether-β-cyclodextrin nanoparticles for cinnamaldehyde entrapment. Zhu W; Wu J; Guo X; Sun X; Li Q; Wang J; Chen L J Food Biochem; 2020 Jun; 44(6):e13197. PubMed ID: 32189350 [TBL] [Abstract][Full Text] [Related]
20. Effect of sulfobutyl ether-β-cyclodextrin and propylene glycol alginate on the solubility of clozapine. Furuishi T; Sekino K; Gunji M; Fukuzawa K; Nagase H; Endo T; Ueda H; Yonemochi E Pharm Dev Technol; 2019 Apr; 24(4):479-486. PubMed ID: 30126299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]